Technology News and Research

RSS

Democrats plan to expand Medicare hearing benefits. What can consumers expect?

President Joe Biden's mammoth domestic spending bill would add hearing benefits to the traditional Medicare program — one of three major new benefits Democrats had sought.

5 Nov 2021

Aptamer Group and DeepVerge expand partnership for Optimer-enabled wastewater monitoring

Aptamer Group Ltd., the developer of Optimer® binders to enable innovation in the life science industry, is pleased to announce the expansion of its existing partnership with DeepVerge PLC.

4 Nov 2021

Automated method shows predictive power for COVID-19 in-hospital mortality

Researchers focussed on the S-learner strategy of estimating the conditional average treatment effect.

4 Nov 2021

INTEGRA Biosciences builds campus for 400 employees in Zizers

International laboratory technology company INTEGRA Biosciences is expanding its head offices in Zizers, Switzerland, with the aim of creating 250 new jobs by 2028.

From INTEGRA Biosciences 4 Nov 2021

Cas13 shines a light on SARS-CoV-2 variants

Now, a new study published on the medRxiv* preprint server describes and benchmarks SHINEv2, a Cas13-based nucleic acid diagnostic for SARS-CoV-2 detection. SHINEv2 combines temperature sample processing and lyophilized reagents to simplify the test procedure and assay distribution immensely.

4 Nov 2021

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology - Enabling solutions for biopharmaceutical development and production -

Yokogawa announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess software and services.

From Yokogawa Electric Corporation 3 Nov 2021

Studying influenza A virus and peptide interactions with electrically controllable DNA nanoconstructs

German scientists used DNA nanolevers to target the interaction between a peptide known as PeB and influenza A.

3 Nov 2021

Waters and Sartorius partner to help bioprocess scientists accelerate clone selection and process development

Waters Corporation and Sartorius announced today they will partner to provide bioprocess experts with direct access to high-quality mass spectrometry (MS) data to accelerate the speed and improve the accuracy of biopharmaceutical process development.

From Sartorius 3 Nov 2021

CHOP-led network receives NIH-supported resources to unlock mysteries behind pediatric brain tumors

Unlocking the genetic mysteries behind pediatric brain tumors is at the heart of the mission of the Center for Data Driven Discovery in Biomedicine (D3b) at Children's Hospital of Philadelphia (CHOP). The Children's Brain Tumor Network (CBTN), a multi-institutional brain tumor research program with its operations center housed at D3b, has collected tumor samples from patients all over the world.

3 Nov 2021

Scientists tackle antibiotic resistance by using supercomputers

Scientists may have made a giant leap in fighting the biggest threat to human health by using supercomputing to keep pace with the impressive ability of diseases to evolve.

3 Nov 2021

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

In an article published in the open-access journal Advance Engineering, a multinational team of researchers reported the selection and characterization of 3 potent SARS-CoV-2 antibodies - S-E6, S-B8, and S-D4 - from a pre-COVID-19 human combinatorial antibody library that was established 20 years ago.

3 Nov 2021

Pregnant women exposed to landscape fire smoke more likely to have low birth weight babies

Women exposed to smoke from landscape fires during pregnancy are more likely to give birth to babies with low or very low birth weights, according to findings published in eLife.

2 Nov 2021

Dutch study compares mRNA vaccines to vector-based vaccines for COVID-19

An overview of the PIENTER-Corona (PiCo) study, which is a Dutch nationwide efficacy comparison study on four different COVID-19 vaccines.

2 Nov 2021

University of Liverpool spin out aims to revolutionize the diagnosis of UTIs

The University of Liverpool has formed a new spin-out company, PhenUtest Diagnostics Ltd, to take forward state-of-the-art medical device technology that aims to revolutionise the diagnosis of Urinary Tract Infections (UTIs).

2 Nov 2021

How cellular clocks regulate cardiac physiology

In this interview, News-Medical speaks to research associate Dr. Alessandra Stangherlin about her latest research that provided new insights into the circadian rhythm of the heart.

2 Nov 2021

UMass Amherst and Brigham launch MassAITC to improve in-home care for Alzheimer's patients

The University of Massachusetts Amherst and Brigham and Women's Hospital announced today the launch of the new Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MassAITC), which seeks to improve in-home care for older adults and individuals with Alzheimer's disease, thanks to a grant from the National Institute on Aging (NIA), which is part of the National Institutes of Health.

1 Nov 2021

Startup receives funding for developing a device to prevent epilepsy-related death

Neurava, a startup located in West Lafayette, Indiana, announced Monday (Nov. 1) that it has received more than $650,000 in seed funding led by Elevate Ventures with participation from Purdue Foundry, First Leaf Capital, UCB Biopharma, iO Life Ventures and angel investors.

1 Nov 2021

Transmission of COVID-19 from pet parent to pet documented for first time in the U.S.

For the first time in the U.S., the transmission of COVID-19 from pet parent to pet is documented genetically as part of a study by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

1 Nov 2021

The Connection between High-sensitivity Troponin and Heart Attacks

This interview outlines the connection between high-sensitivity troponin and heart attacks.

From Siemens Healthineers 1 Nov 2021

Two new studies show how to enhance effectiveness of cancer immunotherapy

Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell carcinoma (OCSCC) and identified potential molecular biomarkers in the blood and tumors of patients that would show how likely it is that someone would respond to immunotherapy.

30 Oct 2021

Technology News and Research

Democrats plan to expand Medicare hearing benefits. What can consumers expect?

Aptamer Group and DeepVerge expand partnership for Optimer-enabled wastewater monitoring

Automated method shows predictive power for COVID-19 in-hospital mortality

INTEGRA Biosciences builds campus for 400 employees in Zizers

Cas13 shines a light on SARS-CoV-2 variants

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology - Enabling solutions for biopharmaceutical development and production -

Studying influenza A virus and peptide interactions with electrically controllable DNA nanoconstructs

Waters and Sartorius partner to help bioprocess scientists accelerate clone selection and process development

CHOP-led network receives NIH-supported resources to unlock mysteries behind pediatric brain tumors

Scientists tackle antibiotic resistance by using supercomputers

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

Pregnant women exposed to landscape fire smoke more likely to have low birth weight babies

Dutch study compares mRNA vaccines to vector-based vaccines for COVID-19

University of Liverpool spin out aims to revolutionize the diagnosis of UTIs

How cellular clocks regulate cardiac physiology

UMass Amherst and Brigham launch MassAITC to improve in-home care for Alzheimer's patients

Startup receives funding for developing a device to prevent epilepsy-related death

Transmission of COVID-19 from pet parent to pet documented for first time in the U.S.

The Connection between High-sensitivity Troponin and Heart Attacks

Two new studies show how to enhance effectiveness of cancer immunotherapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News